XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 29, 2024
Dec. 31, 2023
Dec. 25, 2022
Cash flows from operating activities:      
Net loss $ (90,373) $ (113,384) $ (190,441)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 67,346 59,491 46,471
Amortization of lease acquisition costs 93 92 93
Amortization of loan origination fees 71 55 126
Amortization of cloud computing arrangements 914 880 224
Operating lease cost 31,475 29,113 28,447
Loss on disposal of property and equipment 255 687 278
Stock-based compensation 39,024 49,532 78,736
Impairment and closure costs 1,835 90 2,542
Non-cash restructuring charges 701 5,281 13,026
Deferred income tax (benefit) expense (1,412) 358 1,290
Change in fair value of contingent consideration 6,624 3,475 819
Changes in operating assets and liabilities:      
Account receivable (1,532) (258) (600)
Inventory 82 (686) (480)
Prepaid expenses and other current assets (22) (3,789) (2,637)
Operating lease liabilities (18,318) (22,290) (13,955)
Accounts payable 759 9,871 (4,546)
Accrued payroll and benefits 1,585 6,551 (8,013)
Accrued expenses 3,313 1,163 5,732
Gift card and loyalty liability 1,616 781 177
Other non-current liabilities (646) (533) (458)
Net cash provided by (used in) operating activities 43,390 26,480 (43,169)
Cash flows from investing activities:      
Purchase of property and equipment (84,457) (89,672) (96,889)
Purchase of intangible assets (7,741) (6,115) (5,376)
Security and landlord deposits (13) 122 242
Net cash used in investing activities (92,211) (95,665) (102,023)
Cash flows from financing activities:      
Proceeds from stock option exercise 12,765 5,388 4,758
Payment of contingent consideration (3,868) (10,421) 0
Payment of loan origination fees 0 0 (126)
Payment associated to shares repurchased for tax withholding (2) (166) 0
Net cash (used in) provided by financing activities 8,895 (5,199) 4,632
Net decrease in cash and cash equivalents and restricted cash (39,926) (74,384) (140,560)
Cash and cash equivalents and restricted cash—beginning of year 257,355 331,739 472,299
Cash and cash equivalents and restricted cash—end of year 217,429 257,355 331,739
Supplemental disclosure of cash flow:      
Cash paid for interest 184 50 0
Non-cash investing and financing activities:      
Purchase of property and equipment accrued in accounts payable and accrued expenses 9,791 6,824 7,980
Stock Issued $ 2,132 $ 0 $ 0